Physician profile
Jason L Rolling
NPI 1598856155
$10,529.44
in general payments reported to CMS, 2019-2025
23 companies · $3,275 in 2025
The $3,275 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $926 · 2020: $965 · 2021: $512 · 2022: $3,833 · 2023: $396 · 2024: $623 · 2025: $3,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,536 · Travel and Lodging: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,536.05 |
| Travel and Lodging | $1,758.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $3,443.77 | 2019-2022 | |
| Smith+Nephew, INC. | $2,851.50 | 2020-2025 | Acufex Meniscal Root Repair, Novostitch, Healicoil |
| Depuy Synthes Sales INC. | $1,935.29 | 2019-2025 | Na, Monovisc, Va-Lcp |
| Stryker Corporation | $1,507.12 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Reunion |
| Arthrex, INC. | $105.71 | 2020 | |
| Amgen INC. | $105.05 | 2019-2025 | Evenity, Prolia, Prolia |
| Biorez, INC. | $79.19 | 2022 | |
| Alon Medical Technology | $73.59 | 2024-2025 | |
| Davol INC. | $48.35 | 2022-2023 | |
| Abbvie INC. | $40.99 | 2021-2023 | Avycaz, Dalvance, Teflaro |
| Innovation Technologies INC | $39.70 | 2022-2024 | Irrisept |
| Esaote North America, INC. | $37.96 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $36.93 | 2023 | Seglentis |
| Bioventus LLC | $34.70 | 2021-2023 | Durolane |
| Vericel Corporation | $33.18 | 2023-2025 | Maci |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $33.03 | 2024-2025 | |
| Avanos Medical | $23.73 | 2019 | |
| Acera Surgical, INC. | $23.39 | 2025 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $20.55 | 2024 | Iovera, Exparel |
| Biotissue Holdings INC. | $19.54 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.81 | 2019 | |
| Boston Scientific Corporation | $12.01 | 2021 | |
| Integra Lifesciences Corporation | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Rolling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.